Antares Pharma (ATRS) stock is decreasing on Tuesday morning after the company reported its 2015 fourth quarter results before today’s opening bell.
Antares Pharma
Shares of Antares Pharma Inc (NASDAQ:ATRS) shot up 6.2% during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $2.75 and last traded at $2.75, with a volume of …
BNS9d
Share
Ad hoc announcement - Jersey, 22 March, 2017: Atrium European Real …
Real Estate
ticker=ATRS Nivalis Therapeutics Inc. https://ub.rdinvesting.com/news/?ticker=NVLS Antares Pharma saw its …
Nivalis Therapeutics Inc
Now let's wrap up by turning to slide number 17. When I took this job last January, I expressed my frustration with the stock price and indicated to you that going forward we're going to focus on the things that we can control. …
conference call
A year ago, they were trading at 87 cents. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report …
CNBC10d
Antares Pharma reports
(NASDAQ:ATRS). Analysts are projecting that the stock will reach $3.00 on a short term (1 year) basis. The consensus recommendation, according to Zacks Investment research, is 1.71. Analysts have a mean …
ARRIS International plc
Investors in Antares Pharma Inc. (NASD: ATRS) saw new options begin trading this week, for the October 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATRS options …
Bottom line: The Bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $45.65M - other expenses = $-20.65M for ATRS stock. An improving bottomline implies that …